Search Results 321-330 of 17527 for metformin

  1. Iopamidol (injection route, intra-arterial route, intrathecal route, intravenous route) - Side effects & uses - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Metformin. Other Interactions.

  2. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    ... metformin, acarbose or DPP-4 inhibitors (e.g. sitagliptin and vildagliptin). * Past or current history of pancreatitis, gallstones, history of alcoholism ...

  3. Drugs and Supplements that Start with D - Mayo Clinic

    Dapagliflozin and metformin (oral route) · Dapagliflozin, saxagliptin, and metformin (oral route) · Daprodustat (oral route) · Dapsone (oral route) · Dapsone ...

  4. Colesevelam (oral route) - Side effects & dosage - Mayo Clinic

    Metformin; Olmesartan Medoxomil; Phenytoin; Warfarin. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating ...

  5. Drugs and Supplements that Start with B - Mayo Clinic

    Bio-metFORMIN. Also known as. Metformin (oral route). Bio-Statin. Also known as. Nystatin (oral route). Bio-Tadalafil. Also known as. Tadalafil (oral route).

  6. A Study to Compare Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments for Type 1 Diabetes Patients - Mayo Clinic

    Concurrent use of Afrezza or any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 ...

  7. Selegiline (transdermal route) - Mayo Clinic

    Metformin; Nateglinide; Repaglinide; Tolazamide; Tolbutamide. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

  8. Publications - Rozalina G. McCoy, M.D., M.S. - Mayo Clinic

    Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2022 Apr ...

  9. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

    ... metformin and/or dipeptidyl peptidase 4 inhibitor (DPP-IVi) therapy. Both with doses to be stable for 3 months 4. Negative pregnancy test at Screening for ...

  10. Automated Insulin Delivery in Elderly with Type 1 Diabetes - Mayo Clinic

    Concurrent use of any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...